9.79
-0.11
(-1.11%)
At close: January 31 at 4:00:02 PM EST
10.08
+0.29
+(2.96%)
After hours: January 31 at 6:49:33 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ALTMEYER ANNE Director | Stock Award(Grant) | May 30, 2024 | 2,783 |
CATLIN AVERY W Director | Stock Award(Grant) | May 30, 2024 | 4,350 |
COHEN YUVAL Chief Executive Officer | Conversion of Exercise of derivative security | Jun 18, 2024 | 77,221 |
CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 20, 2024 | -- |
HOLMER ALAN F Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 5,829 |
JACQUES RACHELLE SUZANNE Director | Stock Award(Grant) | May 30, 2024 | 2,783 |
JENKINS JOHN KENNETH M.D. Director | Stock Award(Grant) | May 30, 2024 | 2,816 |
KUNG WINSTON Director | Stock Award(Grant) | Aug 16, 2024 | 5,566 |
MORAN SEAN F Chief Financial Officer | Conversion of Exercise of derivative security | Jun 18, 2024 | 48,605 |
SALZMANN PETER Director | Stock Award(Grant) | May 30, 2024 | 2,783 |
Related Tickers
VTYX Ventyx Biosciences, Inc.
2.0100
-1.95%
OKUR OnKure Therapeutics, Inc.
6.15
+5.49%
NERV Minerva Neurosciences, Inc.
2.3100
-2.94%
TIL Instil Bio, Inc.
22.26
-7.29%
KROS Keros Therapeutics, Inc.
11.40
-2.65%
ASMB Assembly Biosciences, Inc.
14.01
-2.91%
CGEM Cullinan Therapeutics, Inc.
10.56
-3.83%
DYN Dyne Therapeutics, Inc.
14.22
+0.57%
CLRB Cellectar Biosciences, Inc.
0.2514
+0.96%
SPRO Spero Therapeutics, Inc.
0.8566
-1.54%